UC Davis Health tests monoclonal antibodies as potential COVID-19 treatment
EurekAlert!,
Timothy Albertson, chair of internal medicine and specialist in pulmonary and critical care, is leading efforts at UC Davis…
Timothy Albertson, chair of internal medicine and specialist in pulmonary and critical care, is leading efforts at UC Davis…
East Coast Institute for Research, a clinical investigational site in Jacksonville, Florida, will commence a novel clinical…
In January, as a frightening new virus filled hospital wards in Wuhan, China, Stephanie Giordano, a 25-year-old researcher at…
Yesterday, Regeneron Pharmaceuticals, with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), announced it…
What is positioned as a potential life-saving clinical trial is occurring at the brand new research site called AZ Clinical…
Regeneron Pharmaceuticals, with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), is launching Phase III…
Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most…
Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center.
By using both humanized mice and convalescent patients, the researchers from the US and Singapore successfully generated non-comp…
WASHINGTON, June 18 — The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and…
(Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to…
By Nancy Lapid June 17 (Reuters) – The following is a brief roundup of some of the latest scientific studies on the novel…
By Nancy Lapid (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus…
b'b\' By Nancy Lapid \\n (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel…
By Nancy Lapid (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus…
By Nancy Lapid June 17 (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel…
Researchers have proposed a cocktail of two antibodies which they say could provide an effective therapy for COVID-19 patients.
Matthew Frieman, PhD Publication Highlights Process for Yielding Array of Human Antibodies That Target Protein on Virus…
Newswise — Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine…
+ (Foto: Unsplash) Pesquisadores da Faculdade de Medicina da Universidade de Maryland, nos Estados Unidos, avaliaram diversos…
This scanning electron microscope image shows SARS-CoV-2 (yellow)—also known as 2019-nCoV, the virus that causes COVID-19—isolate…
Publication highlights process for yielding array of human antibodies that target protein on virus Researchers at the…
Post Views: 1 Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to…
/peterschreiber.media, stock.adobe.com La Jolla/Kalifornien, Amsterdam/Niederlande, Lebanon/New Hampshire und Tarrytown/New…
Weltweit suchen Wissenschaftler nach Antikörpern, die als Waffe gegen das Coronavirus Sars-CoV-2 eingesetzt werden können.
Gemeinsam stark: Ein Cocktail aus zwei verschiedenen Antikörpern könnte besser gegen Covid-19 helfen als nur ein Immunglobulin …
Researchers at the University of Maryland School of Medicine (UMSOM) evaluated several human antibodies to determine the most…
Regeneron’s preclinical data from antiviral COVID-19 mAbs, Cue test gets EUA and more BioCentury is providing this content for…